Anthracycline-Free Neoadjuvant Therapy With Nab-Paclitaxel and Carboplatin in Non-Luminal Breast Cancer: A Single-Arm Clinical Trial.
Anthracycline-free regimens have attracted growing interest because of less cardiac toxicity, especially in HER2-positive breast cancer when used in combination with trastuzumab and pertuzumab. This prospective, single-center trial (NEOPATH) aimed to assess the efficacy and safety of nab-paclitaxel combined with carbop...